Organization: Isotechnika Inc

Isotechnika receives $21.9M milestone from Roche

Isotechnika Inc, Edmonton, has received $21.9 million from Roche following the completion of its Phase II clinical trial of a new psoriasis drug. The $8.355 million in cash and $13.545 million in equity represents one of the largest milestone payments for a Canadian biotech company. The payment was triggered following positive results from Isotechnika’s trial…